Vaccination

Valneva launches trials of COVID-19 vaccine in UK

French-Austrian biotech firm Valneva said Wednesday it will begin clinical trials of its COVID-19 vaccine candidate in Britain, where the government has already ordered at least 60 million doses.

Diseases, Conditions, Syndromes

Recommendations developed for management of Lyme disease

(HealthDay)—In new evidence-based clinical practice guidelines, published online Nov. 30 in Clinical Infectious Diseases, recommendations are presented for the prevention, diagnosis, and treatment of Lyme disease. The guidelines ...

Diseases, Conditions, Syndromes

Scientists identify protein that protects against Lyme

Yale researchers have discovered a protein that helps protect hosts from infection with the tick-borne spirochete that causes Lyme Disease, a finding that may help diagnose and treat this infection, they report Nov. 11 in ...

Diseases, Conditions, Syndromes

Wistar creates a new synthetic DNA vaccine against Powassan virus

Scientists at The Wistar Institute have designed and tested the first-of-its-kind synthetic DNA vaccine against Powassan virus (POWV), targeting portions of the virus envelope protein. A rapidly reemerging tick-borne disease, ...

Diseases, Conditions, Syndromes

Bat tick found for the first time in New Jersey

A tick species associated with bats has been reported for the first time in New Jersey and could pose health risks to people, pets and livestock, according to a Rutgers-led study in the Journal of Medical Entomology.

page 11 from 33